Match vs 1 year's supply of entecavir

Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries

Author List
Andrew Hill
Dzintars Gotham
Graham Cooke et al.


As NGOs consider the opportunity to scale up treatment of hepatitis B in low- to middle-income countries, it is of value to the broader community to understand the potential minimum cost of large-scale treatment for CHB using standard-of-care treatments.

Tables & Figures

Back to top